Prakt. lékáren. 2022; 18(1): 42-47 | DOI: 10.36290/lek.2022.006

Using phytopharmaceuticals in the management of chronic stress

Vilma Vranová1 Lenka Smejkalová1, 2
1 Farmaceutická fakulta Masarykovy univerzity, Brno
2 Farmaceutická fakulta Univerzity Karlovy, Hradec Králové

Stress is currently considered a major threat to public health. The use of phytopharmaceuticals is one of the ways of managing distinct stress symptoms. Golden root extract (Rhodiola rosea) is a herbal medicinal product that is directly indicated to relieve the symptoms of stress, such as fatigue, feelings of weakness and exhaustion. Before starting hypnotics, it is worth trying medicinal plants with a sedative effect, which particularly include valerian, lemon balm, common hop, purple passionflower, or St. John's wort; lavender extract is a registered anxiolytic of plant origin.

Keywords: stress, herbal medicinal products, rhodiola, valerian, lavender.

Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V. Using phytopharmaceuticals in the management of chronic stress. Pharmacy for Practice. 2022;18(1):42-47. doi: 10.36290/lek.2022.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rokyta R. Fyziologie a patologická fyziologie: pro klinickou praxi. Praha: Grada Publishing; 2015.
    2. Ganong WF. Přehled lékařské fyziologie. Praha: Galén; 2005.
    3. Kolář P. Posilování stresem: cesta k odolnosti. Praha: Euromedia Group; 2021.
    4. SÚKL. SPC Vitango. https://www.sukl.cz/modules/medication/download.php?file=SPC160397.pdf & type=spc & as=vitango­‑spc (přístup 12. 1. 2022).
    5. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481-93. Go to original source... Go to PubMed...
    6. Martin J, Martinová D. Léčivé rostliny s hypnotickým a sedativním účinkem. Prakt lékáren. 2014;10(6):226-229.
    7. SÚKL. SPC Baldriparan. https://www.sukl.cz/modules/medication/download.php?file=SPC158021.pdf & type=spc & as=baldriparan­‑spc (přístup 12. 1. 2022).
    8. EMA. European Union herbal monograph on Valeriana officinalis L., radix. https://www.ema.europa.eu/documents/herbal­‑monograph/final­‑european­‑union­‑herbal­‑monograph­‑valeriana­‑officinalis­‑l­‑radix_en.pdf (přístup 17. 1. 2022).
    9. Gyllenhaal C, Merritt SL, Peterson SD, Block KI, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev. 2000;4(3):229-251. Go to original source... Go to PubMed...
    10. Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2016;188:204-228. Go to original source... Go to PubMed...
    11. Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT. Bioassay­‑guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res. 2009;23(8):1075-1081. Go to original source... Go to PubMed...
    12. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris: Intercept; 1999.
    13. EMA. Community herbal monograph on Humulus lupulus L., flos. https://www.ema.europa.eu/documents/herbal­‑monograph/final­‑community­‑herbal­‑monograph­‑humulus­‑lupulus­‑l­‑flos­‑revision-1_en.pdf (přístup 17. 1. 2022).
    14. Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008;116(3):383-396. Go to original source... Go to PubMed...
    15. Navrátilová Z. Anxiolytika přírodního původu I. Rostliny původní v České republice a rostliny zde pěstované. Kontakt. 2012;14(1):68-84. Go to original source...
    16. Liu M, Hansen PE, Wang G, Qiu L, Dong J, Yin H, Qian Z, Yang M, Miao J. Pharmacological profile of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus). Molecules. 2015;20(1):754-779. Go to original source... Go to PubMed...
    17. Possemiers S, Heyerick A, Robbens V, De Keukeleire D, Verstraete W. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem. 2005;(16):6281-6288. Go to original source... Go to PubMed...
    18. EMA. Community herbal monograph on Passiflora incarnata L., herba. https://www.ema.europa.eu/documents/herbal­‑monograph/final­‑community­‑herbal­‑monograph­‑passiflora­‑incarnata­‑l­‑herba_en.pdf (přístup 17. 1. 2022).Další literatura u autorky a na www.praktickelekarenstvi.cz
    19. Janda K, Wojtkowska K, Jakubczyk K et al.; Passiflora incarnata in Neuropsychiatric Disorders­‑A Systematic Review. Nutrients. 2020;12(12):3894. Go to original source... Go to PubMed...
    20. EMA. Final community herbal monograph on Hypericum perforatum L., herba. https://www.ema.europa.eu/en/documents/herbal­‑monograph/final­‑community­‑herbal­‑monograph­‑hypericum­‑perforatum­‑l­‑herba­‑well­‑established­‑medicinal­‑use_en.pdf (přístup 17. 1. 2022).
    21. Zirak N, Shafiee M, Soltani G, et al. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. J Cell Physiol. 2019;234(6):8496-8508. Go to original source... Go to PubMed...
    22. Russo E, Scicchitano F, Whalley BJ, et al. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug­‑drug interactions. Phytother Res. 2014;28(5):643-655. Go to original source... Go to PubMed...
    23. Seifritz E, Schläfke S, Holsboer­‑Trachsler E. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect. J Psychiatr Res. 2019;115:69-74. Go to original source... Go to PubMed...
    24. Schuwald AM, Nöldner M, et al. Lavender Oil­Potent Anxiolytic Properties via Modulating Voltage Dependent Calcium Channels. PLoS ONE. 2013;8(4):e59998. Go to original source... Go to PubMed...
    25. Sanna MD, Les F, Lopez V, Galeotti N. Lavender (Lavandula angustifolia Mill.) Essential Oil Alleviates Neuropathic Pain in Mice With Spared Nerve Injury. Front Pharmacol. 2019;10:472. Go to original source... Go to PubMed...
    26. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93-107. Go to original source... Go to PubMed...
    27. Katzmam M A, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive­‑compulsive disorders. BMC Psychiatry. 2014;(14)S1. Go to original source... Go to PubMed...
    28. Bandelow B, Werner AM, Kopp I, Rudolf S, Wiltink J, Beutel ME. The German Guidelines for the treatment of anxiety disorders: first revision [published online ahead of print, 2021 Oct 5]. Eur Arch Psychiatry Clin Neurosci. 2021;1-12. Go to original source... Go to PubMed...
    29. Kasper S, Sachs G, Kapfhammer HP, et al. Angststörungen. Medikamentöse Therapie. Konsensus­‑Statement - State of the art 2018. CliniCum neuropsy Sonderausgabe 2018

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.